Keyphrases
Age of Onset
7%
Budesonide
9%
CARD15
11%
Celiac Disease
9%
Clinical Remission
9%
Colitis
14%
Corticosteroids
6%
Crohn's
11%
Crohn's Colitis
7%
Crohn's Disease
93%
Crohn's Disease Exclusion Diet
11%
Diet Therapy
8%
Disease Activity
7%
Disease Course
7%
Disease Groups
10%
Disease Phenotype
8%
Environmental Factors
8%
ESPGHAN
18%
Exclusion Diet
8%
Exclusive Enteral nutrition
19%
Fecal Calprotectin
7%
Feeding Disorders
6%
Helicobacter Pylori (H. pylori)
11%
Inflammation
11%
Inflammatory Bowel Disease
54%
Israel
10%
Malignancy
7%
Metronidazole
7%
Microbiome
7%
Moderate to Severe
15%
New Onset
8%
NOD2
14%
Nutritional Intervention
10%
Partial Enteral nutrition
10%
Pediatric
15%
Pediatric Crohn's Disease
57%
Pediatric Crohn's Disease Activity Index
12%
Pediatric IBD
7%
Pediatric Inflammatory Bowel Disease
27%
Pediatric Onset
22%
Pediatric Patients
10%
Pediatric Ulcerative Colitis
15%
Polymorphism
10%
Porto
22%
Randomized Controlled Trial
15%
Remission
33%
Remission Induction
15%
Ulcerative Colitis
17%
Urea Breath Test
8%
Working Diagnosis
9%
Medicine and Dentistry
Adalimumab
6%
Adolescent
9%
Antibiotics
5%
Budesonide
8%
C Reactive Protein
6%
Cancer
8%
Cohort Analysis
6%
Colitis
14%
Combination Therapy
5%
Crohn's Disease
84%
Crohn's Disease Activity Index
9%
Diet Therapy
10%
Disease
42%
Disease Activity
5%
Disease Course
7%
Elimination Diet
17%
Endoscopy
8%
Enteric Feeding
25%
Faecal Calprotectin
6%
Helicobacter Pylori
10%
Hepatology
6%
Inflammatory Bowel Disease
63%
Microbiome
6%
Patient with Inflammatory Bowel Disease
9%
Pediatric Gastroenterology
7%
Pediatric Nutrition
6%
Pediatrics
100%
Pediatrics Patient
10%
Randomized Controlled Trial
12%
Symptom
12%
Systematic Review
9%
Ulcerative Colitis
25%
Vedolizumab
5%